Vincerx Pharma Statistics

Total Valuation

Vincerx Pharma has a market cap or net worth of $2.52 million. The enterprise value is -$6.03 million.

Market Cap	2.52M
Enterprise Value	-6.03M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Vincerx Pharma has 1.68 million shares outstanding. The number of shares has increased by 47.84% in one year.

Current Share Class	1.68M
Shares Outstanding	1.68M
Shares Change (YoY)	+47.84%
Shares Change (QoQ)	+5.11%
Owned by Insiders (%)	11.34%
Owned by Institutions (%)	17.97%
Float	1.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.27
P/TBV Ratio	0.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.17, with a Debt / Equity ratio of 0.18.

Current Ratio	2.17
Quick Ratio	2.06
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -217.55% and return on invested capital (ROIC) is -120.37%.

Return on Equity (ROE)	-217.55%
Return on Assets (ROA)	-85.42%
Return on Invested Capital (ROIC)	-120.37%
Return on Capital Employed (ROCE)	-295.81%
Revenue Per Employee	n/a
Profits Per Employee	-$643,571
Employee Count	42
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.19% in the last 52 weeks. The beta is 1.19, so Vincerx Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.19
52-Week Price Change	-94.19%
50-Day Moving Average	4.07
200-Day Moving Average	10.77
Relative Strength Index (RSI)	28.04
Average Volume (20 Days)	1,176,210

Short Selling Information

The latest short interest is 1.11 million, so 66.34% of the outstanding shares have been sold short.

Short Interest	1.11M
Short Previous Month	4.71M
Short % of Shares Out	66.34%
Short % of Float	80.82%
Short Ratio (days to cover)	0.80

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-28.17M
Pretax Income	-28.90M
Net Income	-27.03M
EBITDA	-28.12M
EBIT	-28.17M
Earnings Per Share (EPS)	-$17.22

Full Income Statement

Balance Sheet

The company has $10.09 million in cash and $1.64 million in debt, giving a net cash position of $8.45 million or $5.03 per share.

Cash & Cash Equivalents	10.09M
Total Debt	1.64M
Net Cash	8.45M
Net Cash Per Share	$5.03
Equity (Book Value)	9.11M
Book Value Per Share	5.80
Working Capital	6.32M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-27.97M
Capital Expenditures	n/a
Free Cash Flow	-27.97M
FCF Per Share	-$16.67

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Vincerx Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-47.84%
Shareholder Yield	-47.84%
Earnings Yield	-1,118.78%
FCF Yield	-1,157.48%

Analyst Forecast

The average price target for Vincerx Pharma is $2.00, which is 33.33% higher than the current price. The consensus rating is "Buy".

Price Target	$2.00
Price Target Difference	33.33%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 28, 2025. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Jan 28, 2025
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a